MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Angiofibroma

(UMLS:C0206731)

Definition:: A benign neoplasm of fibrous tissue in which there are numerous small and large, frequently dilated, vascular channels. (Stedman, 25th ed)
UMLS ID:: C0206731
MeSH ID:: D018322

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.645.100

Synonym(s)

Angiofibroma

ANGIOFIBROMA

ANGIOFIBROMA, BENIGN

Angiofibroma NOS

Angiofibroma, NOS

Angiofibroma, no ICD-O subtype

Angiofibroma, no International Classification of Diseases for Oncology subtype

Angiofibromas

Angiofibromatous Hyperplasia

10.

Fibroangioma, Benign

11.

Fibrous Papule

12.

Telangiectatic Fibroma

13.

angiofibromatous hyperplasia

14.

fibrous papule

15.

fibrous; papule

16.

papule; fibrous

Associated Drug(s)

	Name	Number of Reports	Data Source
1	Everolimus	FAERS: 7 Canada Vigilance: 1	Canada Vigilance US FAERS
2	Testosterone	FAERS: 4	US FAERS
3	Phenytoin	FAERS: 2	US FAERS
4	Imatinib Mesylate	FAERS: 1	US FAERS
5	Tamoxifen	FAERS: 1	OFFSIDES US FAERS
6	Valproic Acid	FAERS: 1	US FAERS
7	Anastrozole		OFFSIDES
8	Bupropion		OFFSIDES
9	Capecitabine		OFFSIDES
10	Ciprofloxacin		OFFSIDES
11	Clotrimazole		OFFSIDES
12	Dermazin		OFFSIDES
13	Etodolac		OFFSIDES
14	Fulvestrant		OFFSIDES
15	Hydromorphone		OFFSIDES
16	Letrozole		OFFSIDES
17	Meloxicam		OFFSIDES
18	Mupirocin		OFFSIDES
19	Raloxifene Hydrochloride		OFFSIDES
20	Tadalafil		OFFSIDES
21	Venlafaxine Hydrochloride		OFFSIDES
22	Vinorelbine		OFFSIDES
23	Zoledronic Acid		OFFSIDES
24	exemestane		OFFSIDES
25	terconazole		OFFSIDES

Similar ADE(s)

	Name	Semantic Similarity
1	Angiokeratoma	46.7%
2	Hemangioma	46.7%
3	hemangiopericytoma	46.7%
4	Hemangiosarcoma	40.7%
5	Hemangioendothelioma	34.4%
6	leukemia	31%
7	Neoplasms, Germ Cell and Embryonal	31%
8	Neoplasms, Glandular and Epithelial	31%
9	Germ Cell Cancer	31%
10	Hemangioblastoma	28.5%
11	Meningioma	27.9%
12	Neuroectodermal Tumors	26.7%
13	Neoplasms, Neuroepithelial	24.6%
14	Gliomatosis cerebri	24.6%
15	Carcinosarcoma	23.1%
16	lymphangiosarcoma	23.1%
17	melanoma	22%
18	Histiocytic Disorders, Malignant	20.5%
19	Adenoma	20%
20	Ameloblastoma	20%
21	Carcinoma	20%
22	Chordoma	20%
23	Lymphangioma	20%
24	Mesenchymoma	20%
25	Nevus	20%
26	Teratoma	20%
27	Hepatoblastoma	20%
28	Mixed Tumor, Mullerian	20%
29	Germinoma	20%
30	Teratocarcinoma	20%
31	Sarcoma	20%
32	Epithelioma	20%
33	Basal cell carcinoma	19.6%
34	Carcinoma, Papillary	19.6%
35	Squamous cell carcinoma	19.6%
36	Chondrosarcoma	19.6%
37	Craniopharyngioma	19.6%
38	Cystadenoma	19.6%
39	leiomyosarcoma	19.6%
40	liposarcoma	19.6%
41	Mesothelioma	19.6%
42	synovial sarcoma	19.6%
43	Neuroectodermal Tumor, Melanotic	19.6%
44	Angiomyolipoma	19.6%
45	Clear Cell Sarcoma of Soft Tissue	19.6%
46	Alveolar Soft Part Sarcoma	19.6%
47	Neuroendocrine Tumors	19.6%
48	Sarcoma, Myeloid	19.6%
49	Carcinoma, Basal Cell	19.6%
50	Adenoma, Acidophil	19.4%
51	Ganglioneuroma	19.4%
52	Glioma	19.4%
53	Malignant Glioma	19.4%
54	Medulloblastoma	19.1%
55	Carcinoma 256, Walker	18.7%
56	Hamartoma	18.5%
57	Neoplasms, Hormone-Dependent	18.5%
58	Neoplasms, Multiple Primary	18.5%
59	Paraneoplastic Syndromes	18.5%
60	Precancerous Conditions	18.5%
61	Neoplasms, Second Primary	18.5%
62	Carcinoid Tumor	18.1%
63	Neurilemmoma	18.1%
64	Hutchinson's Melanotic Freckle	18.1%
65	Melanoma, Amelanotic	18.1%
66	Cystadenocarcinoma	17.8%
67	Fibrosarcoma	17.8%
68	Osteosarcoma	17.8%
69	Mucoepidermoid Carcinoma	17.8%
70	Sturge-Weber Syndrome	17.6%
71	Hemangioma, Cavernous	17.2%
72	Leukemia, Plasma Cell	17.2%
73	Adenofibroma	17%
74	Fibroadenoma	17%
75	Malignant Fibrous Histiocytoma	17%
76	Carcinoma, Ehrlich Tumor	16.9%
77	Dermoid Cyst	16.9%
78	Carcinoma, Lewis Lung	16.9%
79	Astrocytoma	16.8%
80	Ependymoma	16.8%
81	oligodendroglioma	16.8%
82	Ganglioglioma	16.8%
83	gliosarcoma	16.8%
84	Anaplastic astrocytoma	16.8%
85	Anaplastic Oligodendroglioma	16.8%
86	Malignant Carcinoid Syndrome	16.2%
87	Bowen's Disease	16.1%
88	Paraganglioma	16.1%
89	Rhabdomyosarcoma	16.1%
90	Giant Cell Tumor of Bone	16.1%
91	Composite Lymphoma	15.8%
92	Glioblastoma	15.5%
93	Neuroblastoma	15.5%
94	Glioblastoma Multiforme	15.5%
95	Melanoma, Experimental	15.5%
96	Dermatofibrosarcoma	15.3%
97	Dermatofibrosarcoma Protuberans	15.3%
98	Lymphoma	15.3%
99	Trophoblastic Neoplasms	15.3%
100	Leukemia, Experimental	15.1%
101	Ganglioneuroblastoma	14.9%
102	Adenocarcinoma	14.8%
103	Carcinoma in Situ	14.8%
104	Carcinoma, Transitional Cell	14.8%
105	Phyllodes Tumor	14.8%
106	Dysgerminoma	14.8%
107	Lipoma	14.8%
108	Myoma	14.8%
109	Myxoma	14.8%
110	Neuroma	14.8%
111	Papilloma	14.8%
112	Pseudomyxoma Peritonei	14.8%
113	Seminoma	14.8%
114	Papillomatosis	14.8%
115	Angiolipoma	14.8%
116	Myelolipoma	14.8%
117	Neoplasms, Bone Tissue	14.8%
118	Neoplasms, Fibrous Tissue	14.8%
119	Smooth Muscle Tumor	14.8%
120	Adenomatosis, Pulmonary	14.8%
121	Adenomatous Polyps	14.8%
122	Carcinoma, Large Cell	14.8%
123	Carcinoma, Small Cell	14.8%
124	Desmoplastic Small Round Cell Tumor	14.8%
125	Chondroma	14.8%
126	Enchondroma	14.8%
127	Pheochromocytoma	14.4%
128	Alveolar rhabdomyosarcoma	14.4%
129	Leukemia L1210	14.3%
130	Leukemia P388	14.3%
131	Acanthoma	14.3%
132	Choriocarcinoma	13.4%
133	Carcinoma, Lobular	13.4%
134	Plasmacytoma	13.3%
135	Malignant histiocytosis	13.2%
136	Histiocytic sarcoma	13.2%
137	Sarcoma 180	12.6%
138	Endometrial Stromal Sarcoma	12.6%
139	Sarcoma, Experimental	12.5%
140	Carcinoid Heart Disease	12.4%
141	Thymoma	12.4%
142	Leukemia, Radiation-Induced	12.2%
143	Adenoid Cystic Carcinoma	12.2%
144	Cyst	12.2%
145	fibroma	12.2%
146	Fibromatosis	12.2%
147	Neoplastic Processes	12.2%
148	Neoplastic Syndromes, Hereditary	12.2%
149	Osteoblastoma	12.2%
150	Osteoma	12.2%
151	Pregnancy Complications, Neoplastic	12.2%
152	Rhabdomyoma	12.2%
153	Chondromatosis	12.2%
154	Adenocarcinoma, Clear Cell	12.2%
155	Cholangiocarcinoma	12.2%
156	Cervical Intraepithelial Neoplasia	12.2%
157	Lymphoma, Extranodal NK-T-Cell	12.2%
158	Neoplasms, Experimental	11.9%
159	Lymphangioleiomyomatosis	11.7%
160	Neurofibrosarcoma	11.6%
161	Retinoblastoma	11.1%
162	Fibromatosis, Aggressive	10.9%
163	Fibromatosis, Abdominal	10.9%
164	Klatskin Tumor	10.9%
165	Abdominal Neoplasms	10.3%
166	Erythroplasia	10.3%
167	Follicular cyst	10.3%
168	Head and Neck Neoplasms	10.3%
169	Mucocele	10.3%
170	Pilonidal Cyst	10.3%
171	Soft Tissue Neoplasms	10.3%
172	Thoracic Neoplasms	10.3%
173	Thyroglossal Cyst	10.3%
174	Synovial Cyst	10.3%
175	Aberrant Crypt Foci	10.3%
176	Hodgkin Disease	9.8%
177	Lymphoma, Non-Hodgkin	9.8%
178	Leukemia, Myelomonocytic, Chronic	9.8%
179	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	9.8%
180	Multiple Endocrine Neoplasia	9.2%
181	Neoplasms, Radiation-Induced	8.8%
182	Lymphomatoid Granulomatosis	8.8%
183	Paraneoplastic Encephalomyelitis	8.6%
184	Hydatidiform Mole	8.5%
185	Mammary Neoplasms, Experimental	8.4%
186	Acoustic Neuroma	8.4%
187	Carcinoma, Pancreatic Ductal	8.3%
188	Mastocytoma	8.2%
189	Mastocytosis, Systemic	8.1%
190	Leukemia, Myeloid, Chronic-Phase	8.1%
191	Primary amyloidosis	7.9%
192	Hepatocellular Adenoma	7.9%
193	Basal Cell Nevus Syndrome	7.7%
194	Mastocytosis	7.6%
195	Optic Nerve Glioma	7.5%
196	Nephroblastoma	7.5%
197	Gastrointestinal Stromal Tumors	7.4%
198	Vipoma	7.4%
199	Digestive System Neoplasms	7.3%
200	Endocrine Gland Neoplasms	7.3%
201	Eye Neoplasms	7.3%
202	Leukemia, T-Cell	7.3%
203	Nervous System Neoplasms	7.3%
204	Leukemia, B-Cell	7.3%
205	neurofibroma	7.3%
206	Lymphoma, Follicular	7.3%
207	T-Cell Lymphoma	7.3%
208	Mantle cell lymphoma	7.3%
209	Bone neoplasms	7%
210	Leukoplakia	7%
211	Lymphocele	7%
212	Pancreatic Cyst	7%
213	Skin Neoplasms	7%
214	Hematologic Neoplasms	7%
215	Barrett Esophagus	6.8%
216	Breast Cyst	6.8%
217	Actinic keratosis	6.8%
218	Mediastinal Cyst	6.8%
219	Neoplasm Invasiveness	6.8%
220	Neoplasm Metastasis	6.8%
221	Neoplasm Recurrence, Local	6.8%
222	Parovarian Cyst	6.8%
223	Pericardial Cyst	6.8%
224	Splenic Neoplasms	6.8%
225	Thymic Cyst	6.8%
226	Carcinogenesis	6.8%
227	Myxoid cyst	6.8%
228	Metastasis	6.8%
229	Mesoblastic Nephroma	6.7%
230	Retroperitoneal Neoplasms	6.7%
231	Prolactinoma	6.5%
232	Growth Hormone-Secreting Pituitary Adenoma	6.5%
233	Tuberous Sclerosis	6.1%
234	Multiple Endocrine Neoplasia Type 1	6%
235	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	6%
236	Leukemia, Large Granular Lymphocytic	6%
237	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	6%
238	Lymphoma, T-Cell, Cutaneous	6%
239	Lymphoma, AIDS-Related	6%
240	Enteropathy-Associated T-Cell Lymphoma	6%
241	Primary Effusion Lymphoma	6%
242	insulinoma	5.7%
243	Waldenstrom Macroglobulinemia	5.7%
244	Multiple Myeloma	5.7%
245	Dupuytren Contracture	5.6%
246	granulosa cell tumor	5.5%
247	Carcinoma, Ovarian Epithelial	5.5%
248	Urticaria Pigmentosa	5.5%
249	Parathyroid Neoplasms	5.5%
250	Peritoneal Neoplasms	5.5%
251	Thyroid Neoplasm	5.5%
252	Thyroid carcinoma	5.5%
253	Gastrinoma	5.4%
254	Glucagonoma	5.4%
255	Mycosis Fungoides	5.4%
256	Lymphomatoid Papulosis	5.4%
257	Plasmablastic lymphoma	5.4%
258	Adrenocortical carcinoma	5.4%
259	Adenomatous Polyposis Coli	5.1%
260	Corpus Luteum Cyst	5%
261	Ovarian Cysts	5%
262	Liver Neoplasms, Experimental	5%
263	Leydig Cell Tumor	4.9%
264	Tracheal Neoplasms	4.8%
265	Leukoplakia, Oral	4.6%
266	Paraneoplastic Cerebellar Degeneration	4.6%
267	Pancreatic Neoplasm	4.6%
268	Renal Cell Carcinoma	4.6%
269	Papillary Renal Cell Carcinoma	4.6%
270	Mouth Neoplasms	4.5%
271	Central Nervous System Neoplasms	4.5%
272	Vascular Neoplasms	4.5%
273	Thymus Neoplasms	4.5%
274	Nasopharyngeal carcinoma	4.5%
275	Carcinoma, Endometrioid	4.4%
276	Genital Neoplasms, Female	4.4%
277	Pancreatic Pseudocyst	4.4%
278	Lymphatic Metastasis	4.4%
279	Neoplasms, Unknown Primary	4.4%
280	Leukemic Infiltration	4.4%
281	Breast Neoplasms, Male	4.4%
282	Neoplasm Micrometastasis	4.4%
283	Triple Negative Breast Neoplasms	4.4%
284	Choledochal Cyst	4.1%
285	Burkitt Lymphoma	4%
286	Peutz-Jeghers Syndrome	4%
287	Thyroid Nodule	3.9%
288	Esophageal Neoplasms	3.9%
289	Limbic Encephalitis	3.8%
290	Denys-Drash Syndrome	3.8%
291	Sezary Syndrome	3.6%
292	Adrenal Gland Neoplasms	3.4%
293	Gastrointestinal Neoplasms	3.4%
294	Genital Neoplasms, Male	3.4%
295	Liver neoplasms	3.4%
296	Uveal Neoplasms	3.4%
297	Urologic Neoplasms	3.4%
298	Lambert-Eaton Myasthenic Syndrome	3.3%
299	Testicular Neoplasms	3.3%
300	Sebaceous Gland Neoplasms	3.3%
301	Spinal Neoplasms	3.3%
302	Bone Marrow Neoplasms	3.3%
303	Meningeal Neoplasms	3.3%
304	Polycystic Ovary Syndrome	3.3%
305	Opsoclonus-Myoclonus Syndrome	2.9%
306	Meningeal Carcinomatosis	2.7%
307	Palatal Neoplasms	2.6%
308	Ear Neoplasms	2.6%
309	Eyelid Neoplasms	2.6%
310	Lung Neoplasms	2.6%
311	Pleural Neoplasms	2.6%
312	Myelitis, Transverse	2.6%
313	Nose Neoplasms	2.6%
314	Cell Transformation, Viral	2.5%
315	Brain Neoplasms	2.5%
316	Salivary Gland Neoplasms	2.5%
317	Spinal Cord Neoplasms	2.5%
318	Tongue Neoplasms	2.5%
319	Uterine Neoplasms	2.4%
320	Vaginal Neoplasms	2.4%
321	Vulvar Neoplasms	2.4%
322	Uterine Cancer	2.4%
323	Fallopian Tube Neoplasms	2.4%
324	Xeroderma Pigmentosum	2.2%
325	Pituitary Adenoma	2.2%
326	Pituitary Neoplasms	2.2%
327	ovarian neoplasm	2.2%
328	Bronchial Neoplasms	2.1%
329	Pharyngeal Neoplasms	2.1%
330	Multiple Pulmonary Nodules	2.1%
331	Supratentorial Neoplasms	2%
332	Central Nervous System Cysts	2%
333	Endometrial Neoplasms	2%
334	Bile Duct Neoplasms	2%
335	gallbladder neoplasm	2%
336	Intestinal Neoplasms	2%
337	Penile Neoplasms	2%
338	Prostatic Neoplasms	2%
339	Stomach Neoplasms	2%
340	Polycythemia Vera	1.9%
341	Brain Stem Neoplasms	1.8%
342	Laryngeal neoplasm	1.7%
343	Choroid Plexus Papilloma	1.7%
344	Hypopharyngeal Neoplasms	1.7%
345	Pleural Effusion, Malignant	1.7%
346	Hypopharyngeal Cancer	1.7%
347	Zollinger-Ellison syndrome	1.6%
348	Bladder Neoplasm	1.6%
349	Kidney Neoplasm	1.6%
350	Ureteral Neoplasms	1.6%
351	Urethral Neoplasms	1.6%
352	Parotid Neoplasms	1.6%
353	Prostatic Neoplasms, Castration-Resistant	1.6%
354	Nelson Syndrome	1.6%
355	Tonsillar Neoplasms	1.5%
356	Cerebellar Neoplasms	1.4%
357	Cecal Neoplasms	1.3%
358	Duodenal Neoplasms	1.3%
359	Radicular Cyst	1.2%
360	Appendiceal Neoplasms	1.2%
361	Colonic Neoplasms	1.2%
362	Rectal Neoplasms	1.2%
363	Nasopharyngeal Neoplasms	1.2%
364	Colorectal Neoplasms	1.2%
365	Paranasal Sinus Neoplasms	1%
366	Anus Neoplasms	1%
367	Sigmoid Neoplasms	1%
368	Maxillary Sinus Neoplasms	0.9%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262